- Release Date: 14/06/22 09:04
- Summary: ACW announces Phase 2 trial designs for AD & MDD
- Price Sensitive: Yes
- Download Document 556.64KB
- Forums
- ASX - By Stock
- Ann: ACW announces Phase 2 trial designs for AD & MDD
ACW
actinogen medical limited
Add to My Watchlist
11.1%
!
3.0¢

Ann: ACW announces Phase 2 trial designs for AD & MDD
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.0¢ |
Change
0.003(11.1%) |
Mkt cap ! $85.73M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 3.0¢ | $165.3K | 5.510M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2055500 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 2489868 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2055500 | 0.029 |
1 | 1000000 | 0.028 |
10 | 1313003 | 0.027 |
9 | 3218090 | 0.026 |
14 | 2446589 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 1718440 | 3 |
0.031 | 2036968 | 8 |
0.032 | 1063916 | 7 |
0.033 | 631127 | 8 |
0.034 | 215322 | 4 |
Last trade - 10.00am 15/09/2025 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman and CEO
Hank Holland
Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online